This first-in-man trial is a prospective, multi-center, single blind, randomized, controlled study using the Cinatra voclosporin coated coronary stent system, which will be compared to Atrium’s Cinatra bare
According to the company, patients treated with ecabet sodium achieved a strong positive trend in the objective sign of tear film break-up time and a positive trend in
Following these changes, Lexicon will focus its drug discovery efforts in core therapeutic areas, including immunology, metabolism/cardiology, and ophthalmology, from which it has obtained its multiple drug candidates
After a seven day jury trial, the jury unanimously decided that the SOLiD sequencing technology did not infringe the patent. “We are very pleased with the decisions by
Within the healthcare division, the company’s Imaging and IT segment was the top profit contributor in the first quarter of fiscal 2009, producing a profit of EUR262 million
This study, to be launched in both Canada and the US, will be an open, multi-center trial treating patients with addictions to assess the effectiveness of using the
High-end tests such as genetics and molecular biology, which are labour-intensive, are sent to India as they can be serviced at nearly one-eighth the costs of developed markets.
The double-blind, randomized, placebo-controlled 12-week study in up to 80 patients with confirmed eosinophilic esophagitis (EoE) aged two to 18 is designed to evaluate three different doses of
Todd Motto, vice president of sales and marketing, Meridian Bioscience commented, “Following a thorough evaluation of the Australian and Argentinean markets, it is clear that Immuno Pty and
Before joining Amylin, Mr Mihalik was vice president of global brand development diabetes and endocrine platform team leader at Eli Lilly and Company. Mr Mihalik will oversee marketing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.